We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VPG:NYSEVishay Precision Group, Inc. Analysis

Data as of 2026-09-01 - not real-time

$61.81

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $61.81, Vishay Precision Group, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 40.5%. With RSI at 36.1 the momentum picture is approaching oversold, alongside a bullish MACD signal. Price has been bracketed by support at $60.09 and resistance at $102.12.
Multiples put this in fair territory: 206.0 times earnings against the sector's 35.8. Consensus targets land 51.0% above where the shares trade now. Revenue is growing at 11.7% on a 1.2% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 131.3%, a beta of 3.06 and a maximum drawdown of 58.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.

Top Market Events

CHESTERBROOK, Pa., July 15, 2026 GLOBE NEWSWIRE -- Vishay Precision Group, Inc. NYSE: VPG , a leader in precision...CHESTERBROOK, Pa., Aug. 05, 2026 GLOBE NEWSWIRE -- Vishay Precision Group, Inc. NYSE: VPG , a leader in precision...CHESTERBROOK, Pa., Aug. 05, 2026 GLOBE NEWSWIRE -- Vishay Precision Group, Inc. NYSE: VPG , a leader in precision...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 67.63
  • MACD momentum is positive
  • 30-day price change of -40.5%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 206.0 versus sector average of 35.8
  • Trading below the 200-day average of 67.63
  • Analyst targets imply +51.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 206.0 versus sector average of 35.8
  • Analyst targets imply +51.0% versus the current price
  • Revenue growth of +11.7%

Key Metrics & Analysis

Financial Health

Revenue Growth11.70%
Profit Margin1.20%
P/E Ratio206.0
ROE1.21%
ROA1.07%
Debt/Equity11.80
P/B Ratio2.5
Op. Cash Flow$2.8M
Free Cash Flow$6.5M
Industry P/E35.8

Technical Analysis

TrendNeutral
RSI36.1
Support$60.09
Resistance$102.12
MA 20$70.23
MA 50$97.27
MA 200$67.63
MACDBullish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$12.87
Target Price$93.33
Upside/Downside51.00%
GradeFair
TypeGrowth

Risk Assessment

Beta3.06
Volatility131.34%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.